PRETERM LABOR AND FETAL SEQUELAE: ROLE OF MYCOPLASMAS

早产和胎儿后遗症:支原体的作用

基本信息

  • 批准号:
    7561865
  • 负责人:
  • 金额:
    $ 7.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We developed the first experimental model in nonhuman primates in which infection is established by intraamniotic inoculation of known quantities of lower genital tract mycoplasmas. Following experimental intraamniotic infection (IAI) with Ureaplasma parvum in long-term catheterized, pregnant rhesus monkeys, there is a sequential upregulation of proinflammatory cytokines (interleukin-1beta, tumor necrosis factor alpha, IL-6, IL-8) prostaglandins (PGE2 and PGF2alpha), and matrix metalloproteinase-9 (MMP-9) which rise in parallel with counts for ureaplasma colonies. This is followed in all cases by uterine contraction, labor and delivery. There is associated fetal lung damage in alveoli and terminal airways. It is our working hypothesis that prenatal treatment of intrauterine U. parvum infection with appropriate antibiotics and specific inflammatory agents will inhibit preterm labor, delay premature delivery, and ameliorate or prevent fetal/neonatal lung disease.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MILES J. NOVY其他文献

MILES J. NOVY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MILES J. NOVY', 18)}}的其他基金

ORAL OXYTOCIN ANTAGONIST PHARMACODYNAMICS IN PREGNANT/NONPREGNANT RHESUS MONKEY
口服催产素拮抗剂在怀孕/非怀孕恒河猴中的药效学
  • 批准号:
    7715939
  • 财政年份:
    2008
  • 资助金额:
    $ 7.59万
  • 项目类别:
PRETERM LABOR AND FETAL SEQUELAE: ROLE OF MYCOPLASMAS
早产和胎儿后遗症:支原体的作用
  • 批准号:
    7715872
  • 财政年份:
    2008
  • 资助金额:
    $ 7.59万
  • 项目类别:
PRIMATE DECIDUA AND FETAL MEMBRANES AS A PARACRINE SYSTEM
灵长类蜕膜和胎膜作为旁分泌系统
  • 批准号:
    7715891
  • 财政年份:
    2008
  • 资助金额:
    $ 7.59万
  • 项目类别:
PRIMATE DECIDUA AND FETAL MEMBRANES AS A PARACRINE SYSTEM
灵长类蜕膜和胎膜作为旁分泌系统
  • 批准号:
    7561891
  • 财政年份:
    2007
  • 资助金额:
    $ 7.59万
  • 项目类别:
ORAL OXYTOCIN ANTAGONIST PHARMACODYNAMICS IN PREGNANT/NONPREGNANT RHESUS MONKEY
口服催产素拮抗剂在怀孕/非怀孕恒河猴中的药效学
  • 批准号:
    7561969
  • 财政年份:
    2007
  • 资助金额:
    $ 7.59万
  • 项目类别:
PRETERM LABOR AND FETAL SEQUELAE: ROLE OF MYCOPLASMAS
早产和胎儿后遗症:支原体的作用
  • 批准号:
    7348876
  • 财政年份:
    2006
  • 资助金额:
    $ 7.59万
  • 项目类别:
PRETERM LABOR AND FETAL SEQUELAE: ROLE OF MYCOPLASMAS
早产和胎儿后遗症:支原体的作用
  • 批准号:
    7165184
  • 财政年份:
    2005
  • 资助金额:
    $ 7.59万
  • 项目类别:
MATERNAL-FETAL-AMNIOTIC FLUID PHARMACOKINETICS OF IL-1RA AND UTERINE ACTIVITY
IL-1RA 的母体-胎儿-羊水药代动力学和子宫活性
  • 批准号:
    7165202
  • 财政年份:
    2005
  • 资助金额:
    $ 7.59万
  • 项目类别:
HUMAN DECIDUA AND FETAL MEMBRANES AS A PARACRINE SYSTEM
人类蜕膜和胎膜作为旁分泌系统
  • 批准号:
    7165226
  • 财政年份:
    2005
  • 资助金额:
    $ 7.59万
  • 项目类别:
MATERNAL-FETAL-AMNIOTIC FLUID PHARMACOKINETICS OF IL-1RA AND UTERINE ACTIVITY
IL-1RA 的母体-胎儿-羊水药代动力学和子宫活性
  • 批准号:
    6970639
  • 财政年份:
    2004
  • 资助金额:
    $ 7.59万
  • 项目类别:

相似海外基金

Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
  • 批准号:
    2902098
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Studentship
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
  • 批准号:
    EP/Z533026/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Research Grant
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
  • 批准号:
    BB/Y004035/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
  • 批准号:
    FT230100468
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
  • 批准号:
    MR/Y033809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
  • 批准号:
    494853
  • 财政年份:
    2023
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
  • 批准号:
    2904356
  • 财政年份:
    2023
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了